DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC.
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.
Nutr Metab (Lond) 2009;
6: 31
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.